For results to be truly scientific and unbiased, you would need to get suitable patients with Aortic stenosis (where a Cardiologist deemed TAVR to be indicated) to be randomised into a properly designed randomised double blind trial to either get 1/ AVR's TAVR or 2/ a competing products TAVR.
Where nobody - the clinician, patient or data collecting team knew which valve the patient received.
For proper scientific outcome, it should have nothing to do with "which company" or "what competitor" is involved.
They would not be involved at all in the scientific process.
All they would do is supply the valve (unmarked and as "blinded" as they could to the operators and those collecting the results).
Cheers
(IMO)
- Forums
- ASX - By Stock
- AVR
- Ann: Capital Raise
Ann: Capital Raise, page-48
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.11 |
Change
-0.570(3.64%) |
Mkt cap ! $335.8M |
Open | High | Low | Value | Volume |
$15.70 | $15.94 | $15.02 | $223.7K | 14.33K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 170 | $15.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.38 | 128 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 225 | 15.110 |
1 | 450 | 15.100 |
1 | 90 | 15.020 |
1 | 15 | 15.010 |
1 | 332 | 15.000 |
Price($) | Vol. | No. |
---|---|---|
15.380 | 128 | 2 |
15.560 | 786 | 1 |
15.570 | 779 | 1 |
15.900 | 75 | 1 |
15.930 | 250 | 1 |
Last trade - 13.30pm 19/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |